April 18, 2025

Retinal Imaging Captures Alzheimer’s and Dementia Risk

The noninvasive, accessible, and scalable modality can predict risk before disease endpoints can be observed.

Conexiant

April 18, 2025

Improvements in OCT Imaging Performance, Processing, and Analysis 

“We can expect instruments to continue to improve as hardware does, and image analysis techniques to improve as more powerful machine learning algorithms are introduced,” study authors wrote.

Conexiant

April 18, 2025

Glaucomatous Progression in 1 in 4 Patients With Myopia

Patients with a family history of glaucoma were more likely to experience progression or RNFL thinning

Conexiant

April 17, 2025

FDA Reviews Eylea HD for RVO

The agency has initiated priority review of the anti-VEGF agent as a treatment for macular edema secondary to retinal vein occlusion.

Ophthalmology Management

April 17, 2025

Accuracy of AI-Based Retinal Photographic CVD Risk Assessment

Predictive accuracy of the tool was comparable to the traditional WHO assessment for 10-year CVD events.

Conexiant

April 14, 2025

Macular Thickness as a Noninvasive Biomarker for Postoperative Delirium

Interocular asymmetry in retinal structure is common and may be influenced by hemispheric differences in neurodegeneration.

Conexiant

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

April 02, 2025

Study Updates Diabetic Retinal Disease Prevalence and Incidence Data

The most recent studies on this data are at least 15 years old and do not reflect the changing landscape of treatments and technology

Conexiant